i remember sometime ago ( i believe a few months before ponatinib approval), the harv was giving a tv interview to fox business with liz claman. in that interview he stated that ariads future undoubtedly lies with the approval and maturation of ponatinib. one year later, the crash occurred. as in harveys own words, ariads future came into doubt. skip to the present day and ariad is now functioning on borrowed time. the company has the goods, but not enough left in the tank for full development of those goods. a buyout is the reasonable option, because as the ceo harv stated, without ponas success, its unlikely for a prosperous future.
News 
Market Data 
Discover 
AI
